SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Speculating in Takeover Targets
CTG 7.075-0.2%Jan 30 1:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: richardred who wrote (4332)1/17/2017 12:23:54 PM
From: richardred  Read Replies (1) of 6544
 
Added to HBIO today. Hedge funds have a sizable interest. The company has been unsuccessful in bringing about a higher stock currently, than a previous PE bid. URL below is why it's in 2017 Top Ten SITT list. IMO the company is more undervalued now than then. The company even trades at a greater discount from the stingy TO bid that was made in 2007. Reminds me of an old successful TO favorite NBSC . Eppendorf To Acquire New Brunswick Scientific For $110Mln [NBSC]. They say it's rare for lightning to strike twice in the same place. However IMO HBIO is holding a ROD.

siliconinvestor.com

P.S.

in-pharmatechnologist.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext